NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.500
0.00 (0.00%)
Apr 25, 2025, 12:02 PM EDT - Market open
NLS Pharmaceutics AG Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Cash & Equivalents | 0.55 | 0.9 | 8.95 | 5.43 | 0.09 | 0.22 | Upgrade
|
| Cash & Short-Term Investments | 0.55 | 0.9 | 8.95 | 5.43 | 0.09 | 0.22 | Upgrade
|
| Cash Growth | -66.53% | -89.97% | 64.76% | 5695.69% | -57.46% | 3198.40% | Upgrade
|
| Other Receivables | 0.08 | 0.04 | 0.04 | 0.04 | 0.06 | 0.08 | Upgrade
|
| Receivables | 0.08 | 0.04 | 0.04 | 0.04 | 0.06 | 0.15 | Upgrade
|
| Prepaid Expenses | 0.3 | 0.07 | 0.19 | 0.22 | 0.01 | 0.02 | Upgrade
|
| Other Current Assets | 0.26 | 0.82 | 0.07 | 0.04 | 0.03 | - | Upgrade
|
| Total Current Assets | 1.19 | 1.82 | 9.25 | 5.72 | 0.2 | 0.38 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.01 | 0.02 | 0.03 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.95 | 0.26 | Upgrade
|
| Other Long-Term Assets | - | 0.02 | 0.01 | 0.01 | 0.07 | 0.05 | Upgrade
|
| Total Assets | 1.19 | 1.85 | 9.28 | 5.76 | 1.21 | 0.7 | Upgrade
|
| Accounts Payable | 4.58 | 4.63 | 2.37 | 1.74 | 4.01 | 2.51 | Upgrade
|
| Accrued Expenses | 1.42 | 1.54 | 0.97 | 0.65 | 1.25 | 0.82 | Upgrade
|
| Short-Term Debt | 1.71 | 1.63 | - | - | 1.16 | 0.54 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.61 | 0.15 | Upgrade
|
| Other Current Liabilities | - | 0.11 | 0.01 | 0.02 | 0.18 | 0.01 | Upgrade
|
| Total Current Liabilities | 7.72 | 7.92 | 3.36 | 2.4 | 7.2 | 4.04 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.31 | 0.15 | Upgrade
|
| Long-Term Unearned Revenue | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | Upgrade
|
| Total Liabilities | 10.46 | 10.68 | 6 | 5.22 | 10.2 | 6.87 | Upgrade
|
| Common Stock | 0.81 | 0.73 | 0.67 | 0.34 | 0.15 | 0.15 | Upgrade
|
| Additional Paid-In Capital | 62.33 | 61.03 | 60.86 | 42.08 | 20.65 | 20.6 | Upgrade
|
| Retained Earnings | -72.41 | -70.37 | -58.2 | -41.71 | -29.76 | -26.9 | Upgrade
|
| Treasury Stock | - | -0.06 | - | -0.03 | - | - | Upgrade
|
| Comprehensive Income & Other | 0 | -0.16 | -0.05 | -0.15 | -0.02 | -0.02 | Upgrade
|
| Shareholders' Equity | -9.27 | -8.83 | 3.28 | 0.54 | -8.98 | -6.17 | Upgrade
|
| Total Liabilities & Equity | 1.19 | 1.85 | 9.28 | 5.76 | 1.21 | 0.7 | Upgrade
|
| Total Debt | 1.71 | 1.63 | - | - | 2.08 | 0.84 | Upgrade
|
| Net Cash (Debt) | -1.16 | -0.74 | 8.95 | 5.43 | -1.99 | -0.62 | Upgrade
|
| Net Cash Growth | - | - | 64.76% | - | - | - | Upgrade
|
| Net Cash Per Share | -1.16 | -0.77 | 18.19 | 18.25 | -11.44 | -3.64 | Upgrade
|
| Filing Date Shares Outstanding | 0.99 | 1 | 0.81 | 0.37 | 0.3 | 0.17 | Upgrade
|
| Total Common Shares Outstanding | 0.99 | 0.81 | 0.81 | 0.37 | 0.17 | 0.17 | Upgrade
|
| Working Capital | -6.53 | -6.1 | 5.89 | 3.32 | -7.01 | -3.65 | Upgrade
|
| Book Value Per Share | -9.40 | -10.90 | 4.05 | 1.47 | -51.63 | -35.47 | Upgrade
|
| Tangible Book Value | -9.27 | -8.83 | 3.28 | 0.54 | -8.98 | -6.17 | Upgrade
|
| Tangible Book Value Per Share | -9.40 | -10.90 | 4.05 | 1.47 | -51.63 | -35.47 | Upgrade
|
| Machinery | - | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.